Skip to main content
. Author manuscript; available in PMC: 2011 Aug 25.
Published in final edited form as: J Nucl Med. 2010 Dec 13;52(1):24–32. doi: 10.2967/jnumed.110.079459

FIGURE 2.

FIGURE 2

Competition assays with 3H-PK11195 and unlabeled TSPO ligand using brain tissue previously characterized as HAB, LAB, or MAB by PBR28 assays. Each data point represents mean value of at least 4 subjects, and error bars represent SEM. (A) Phenoxyphenyl acetamide derivatives. (B) Bicyclic linker derivatives. (C) Phenyl–isoquinolinecarboxamide derivatives. Conc = concentration; SB = specific binding.